Barclays’s NEOPHOTONICS CORP NPTN Stock Holding History

Barclays’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,500	Closed	-$16K	–	7457
2018 Q4	$16K	Buy	+2,500	New	+$19.1K	﹤0.01%	6009

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Barclays's NPTN Position: Q3 2022 in Review

Barclays sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 21,042 shares — an estimated $331K sold.

Barclays first reported a position in NPTN in Q2 2013 and held it in 34 quarters. The position peaked at $1.79M in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Barclays reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Barclays sold 21,042 NEOPHOTONICS CORP shares in Q3 2022, an estimated $331K.
Barclays first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 34 quarters.
Barclays's NEOPHOTONICS CORP position peaked at $1.79M in Q4 2021.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.